Terms: = Thyroid cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
11 results:
1. Association Between a History of Breast cancer and Decreased thyroid cancer-specific Mortality.
Lin S; Wang Z; Xing M
J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
[TBL] [Abstract] [Full Text] [Related]
2. Multiple primary non-breast tumors in breast cancer survivors.
Corso G; Veronesi P; Santomauro GI; Maisonneuve P; Morigi C; Peruzzotti G; Intra M; Sacchini V; Galimberti V
J Cancer Res Clin Oncol; 2018 May; 144(5):979-986. PubMed ID: 29502170
[TBL] [Abstract] [Full Text] [Related]
3. A quantitative study about thyroid stunning after diagnostic whole-body scanning with 74 MBq 131I in patients with differentiated thyroid carcinoma.
Yin Y; Mao Q; Chen S; Li N; Li X; Li Y
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):455-61. PubMed ID: 26416037
[TBL] [Abstract] [Full Text] [Related]
4. Assessing the Validity of Transcutaneous Laryngeal Ultrasonography (TLUSG) After thyroidectomy: What Factors Matter?
Wong KP; Lang BH; Chang YK; Wong KC; Chow FC
Ann Surg Oncol; 2015; 22(6):1774-80. PubMed ID: 25323472
[TBL] [Abstract] [Full Text] [Related]
5. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract] [Full Text] [Related]
6. Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence.
Sheikh HA; Tometsko M; Niehouse L; Aldeeb D; Swalsky P; Finkelstein S; Barnes EL; Hunt JL
Am J Surg Pathol; 2004 Jan; 28(1):101-6. PubMed ID: 14707871
[TBL] [Abstract] [Full Text] [Related]
7. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract] [Full Text] [Related]
8. A kindred of multiple endocrine neoplasia type 2B.
Yamamoto S; Morimoto I; Fujihira T; Watanabe K; Zeki K; Yoshimoto K; Zeze F; Eto S
Endocrinol Jpn; 1992 Feb; 39(1):25-30. PubMed ID: 1351466
[TBL] [Abstract] [Full Text] [Related]
9. Oncogene and growth factor expression in MEN 2 and related tumors.
Moley JF; Wallin GK; Brother MB; Kim M; Wells SA; Brodeur GM
Henry Ford Hosp Med J; 1992; 40(3-4):284-8. PubMed ID: 1362425
[TBL] [Abstract] [Full Text] [Related]
10. Oncoprotein immunoreactivity in human endocrine tumours.
Roncalli M; Springall DR; Varndell IM; Gaitonde VV; Hamid Q; Ibrahim NB; Grimelius L; Wilander E; Polak JM; Coggi G
J Pathol; 1991 Feb; 163(2):117-27. PubMed ID: 1673155
[TBL] [Abstract] [Full Text] [Related]
11. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
[TBL] [Abstract] [Full Text] [Related]
